Advanced search
Publication Cover
Journal of Blood Medicine Volume 11, 2020 - Issue
Submit an article Journal homepage
104
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies

Renchi Yang1 Thrombosis and Hemostasis Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Yongqiang Zhao2 Department of Hematology, Peking Union Medical College Hospital, Beijing, People’s Republic of ChinaView further author information
,
Xuefeng Wang3 Department of Clinical Blood Transfusion, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Jing Sun4 Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-5130-4835View further author information
ORCID Icon,
Runhui Wu5 Department of Hematology, Beijing Children’s Hospital and Capital Medical University, Beijing, People’s Republic of ChinaView further author information
,
Chenghao Jin6 Department of Hematology, Jiangxi Provincial People’s Hospital, Jiangxi, People’s Republic of ChinaView further author information
,
Jie Jin7 Department of Hematology, The First Affiliated Hospital – Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaView further author information
,
Depei Wu8 Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Pablo Rendo9 Rare Disease, Pfizer Inc, Collegeville, PA, USAView further author information
,
Feifei Sun10 Pfizer (China) Research & Development Co, Ltd, Shanghai, People’s Republic of ChinaView further author information
,
Jeremy Rupon9 Rare Disease, Pfizer Inc, Collegeville, PA, USAView further author information
,
Francois Huard11 Clinical Pharmacology, Pfizer PIO, Paris, FranceView further author information
,
Joan M Korth-Bradley12 Pfizer Inc, Collegeville, PA, USAView further author information
,
Lihong Xu10 Pfizer (China) Research & Development Co, Ltd, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-9334-1271View further author information
ORCID Icon,
Binyu Luo10 Pfizer (China) Research & Development Co, Ltd, Shanghai, People’s Republic of ChinaView further author information
&
Yingxue Cathy Liu13 Statistics, Pfizer (China) Research & Development Co, Ltd, Shanghai, People’s Republic of ChinaView further author information
 show all
Pages 439-448 | Published online: 25 Nov 2020

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.